Free Trial

Herbalife Ltd (NYSE:HLF) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.

Herbalife logo with Retail/Wholesale background

Key Points

  • Connor Clark & Lunn Investment Management Ltd. increased its stake in Herbalife Ltd by 18.5%, now owning approximately 0.71% of the company worth $6.25 million after acquiring an additional 113,015 shares.
  • In recent trading, Herbalife stock has gained 2.9%, opening at $9.17, with a market capitalization of $945.11 million.
  • Herbalife's Q2 earnings report showed an EPS of $0.59, surpassing estimates, while revenue was down 1.7% year-over-year, totaling $1.26 billion.
  • MarketBeat previews the top five stocks to own by October 1st.

Connor Clark & Lunn Investment Management Ltd. raised its position in Herbalife Ltd (NYSE:HLF - Free Report) by 18.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 723,968 shares of the company's stock after acquiring an additional 113,015 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.71% of Herbalife worth $6,248,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Herbalife by 10.9% during the first quarter. Vanguard Group Inc. now owns 12,495,374 shares of the company's stock worth $107,835,000 after purchasing an additional 1,223,957 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its position in shares of Herbalife by 67.0% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 2,570,226 shares of the company's stock valued at $17,195,000 after purchasing an additional 1,031,078 shares during the period. Long Focus Capital Management LLC grew its position in shares of Herbalife by 27.3% in the fourth quarter. Long Focus Capital Management LLC now owns 4,758,127 shares of the company's stock valued at $31,832,000 after purchasing an additional 1,020,127 shares during the period. Marshall Wace LLP grew its position in shares of Herbalife by 83.8% in the fourth quarter. Marshall Wace LLP now owns 1,444,343 shares of the company's stock valued at $9,663,000 after purchasing an additional 658,536 shares during the period. Finally, Ameriprise Financial Inc. grew its position in shares of Herbalife by 218.5% in the fourth quarter. Ameriprise Financial Inc. now owns 812,692 shares of the company's stock valued at $5,437,000 after purchasing an additional 557,518 shares during the period.

Herbalife Trading Up 2.6%

HLF traded up $0.24 during trading hours on Friday, hitting $9.59. 1,868,916 shares of the company's stock were exchanged, compared to its average volume of 2,119,540. Herbalife Ltd has a 12-month low of $5.04 and a 12-month high of $10.83. The firm has a 50 day moving average of $9.11 and a 200 day moving average of $7.89. The firm has a market cap of $988.82 million, a P/E ratio of 3.03, a price-to-earnings-growth ratio of 0.29 and a beta of 0.85.

Herbalife (NYSE:HLF - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.59 EPS for the quarter, beating analysts' consensus estimates of $0.53 by $0.06. Herbalife had a net margin of 6.59% and a negative return on equity of 27.36%. The company had revenue of $1.26 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the firm posted $0.54 EPS. The company's quarterly revenue was down 1.7% compared to the same quarter last year. As a group, research analysts expect that Herbalife Ltd will post 1.57 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Citigroup lowered their price target on shares of Herbalife from $13.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Wall Street Zen downgraded shares of Herbalife from a "strong-buy" rating to a "buy" rating in a research note on Sunday, August 10th. Finally, Mizuho boosted their price target on shares of Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a research note on Monday, July 28th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $11.50.

View Our Latest Analysis on Herbalife

Insider Activity at Herbalife

In related news, Director Juan Miguel Mendoza bought 5,000 shares of the company's stock in a transaction that occurred on Thursday, May 22nd. The shares were purchased at an average cost of $6.75 per share, with a total value of $33,750.00. Following the transaction, the director directly owned 166,857 shares of the company's stock, valued at approximately $1,126,284.75. This represents a 3.09% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.73% of the company's stock.

About Herbalife

(Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Read More

Institutional Ownership by Quarter for Herbalife (NYSE:HLF)

Should You Invest $1,000 in Herbalife Right Now?

Before you consider Herbalife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.

While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.